AstraZeneca buys US biotech firm CinCor

Anglo-Swedish pharmaceuticals giant AstraZeneca on Monday agreed to buy US biotech company CinCor for $1.8 billion, expanding further into the field of heart and kidney drugs.

source https://medicalxpress.com/news/2023-01-astrazeneca-buys-biotech-firm-cincor.html